Cambridge’s life sciences market is still the top dog in the country, but it is a vastly different one than what real estate professionals remember from just a few years ago. As the market's life sciences development pipeline continues to slow, Cambridge’s demand, while still stronger than the majority of the country, is also cooling. At the end of the second quarter, the market posted 192K SF of negative net absorption, the first time recording an occupancy loss since the first quarter of 2022, according to CBRE. Experts speaking at Bisnow's Cambridge State of the Market event, held last month at the Holiday Inn Boston Bunker Hill in Somerville, said the market they are seeing today is being driven by smaller early stage companies and a normalizing venture capital funding cycle that is down from its pandemic-era peak. 
“We’re dealing with a demand issue,” Patrick Mulvihill, senior vice president of Boston Properties, said at the event. “I do think it is short-lived, but it’s generally because of what is happening in the macro economy and venture capital.”Although Kendall Square still has one…  Read the full story here. | 
